For citations:
Bessmeltsev1 S.S., Kariagina E.V., Stelmashenko L.V., Salogub G.N., Machulaitene E.R., Abdulkadyrov K.M., Kotova N.A., Kostroma I.I., Medvedeva N.V., Krylova L.I., Ilushkina E.Yu. Lenalidomide for relapsed or refractory multiple myeloma. Oncohematology. 2012;7(1):6-14. (In Russ.) https://doi.org/10.17650/1818-8346-2012-7-1-6-14
Email this article 